Bellevue Hospital-Lab is categorized under in Schenectady, NY and active since 2009.
Bellevue Hospital-Lab was established in 2009, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 6221100 by the NAICS.
If you are seeking more information, feel free to contact James Connolly, Chief Executive Officer at the company’s single location by writing to 2210 Troy Schenectady Road, Schenectady, New York NY 12309 or by phoning (518) 346-9492. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bellevue Hospital-Lab |
| Contact Person: | James Connolly, Chief Executive Officer |
| Address: | 2210 Troy Schenectady Road, Schenectady, New York 12309 |
| Phone Number: | (518) 346-9492 |
| Website Address: | ellismedicine.org |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 8069 |
| NAICS Code: | 6221100 |
| Share This Business: |
Bellevue Hospital-Lab was started in 2009 to provide professional under the SIC code 8069 and NAICS code 6221100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact James Connolly, Chief Executive Officer for inquiries that concern Bellevue Hospital-Lab by calling the company number (518) 346-9492, as your correspondence is most welcome. Additionally, the physical location of the single location of Bellevue Hospital-Lab can be found at the coordinates 42.79358,-73.87913 as well as the street address 2210 Troy Schenectady Road in Schenectady, New York 12309.
For its online presence, you may visit Bellevue Hospital-Lab’s website at ellismedicine.org and engage with its social media outlets through on Twitter and on Facebook.